T-Spot tests (IGRA) for diagnosis of TB infection in contacts, presumptive TB cases and high risk…

Quest Diagnostics has been awarded a contract (PO05422230) by the Virginia Department of Health effective July 28, 2026, with a cumulative contract value of $15,000.00. The contract is structured as a single line item delivery for diagnostic testing services to support public health initiatives within the Commonwealth of Virginia.

The primary deliverable under this contract consists of T-Spot tests, which are Interferon-Gamma Release Assays (IGRA) used for the diagnosis of tuberculosis infection. These diagnostic tests are designated for administration to tuberculosis contacts, presumptive tuberculosis cases, and high-risk populations, with delivery directed to Jewell Wilson. The contract specifies a quantity of one unit at a unit price of $15,000.00, representing the total contract value. While the specific period of performance and geographic place of performance beyond the Virginia Department of Health are not explicitly stated in the award documentation, the testing services are intended to support the Department's tuberculosis screening and diagnostic protocols.